Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by ScootsMcgootson Feb 07, 2024 4:08pm
141 Views
Post# 35868344

RE:RE:Oncy is a Cult Pt. 2

RE:RE:Oncy is a Cult Pt. 2Glad I gave up on ONCY a while back now just watching the show unfold, saved myself a pounding. Regarding PDAC/CRC. Just invest in $AGEN. They are filing a BLA in MSS-CRC 2L+3L mid year and are on track to file an AA in 2L PDAC before Eoy as well with the potential to move up the line in the near term. Regarding immunotherapy 2.0 it is going to be dual checkpoint blockade then cancer vaccines and other therapies will come next on top, but first dual checkpoint. Not my own opinion but KOL's whom I listen to who are not named NOTEABLE aka the unscientist mascarading as someone who actually knows anything. And not one or two KOL's either, but many and their voice in unison. BioNTech bought a CLTA company a year ago as well and is now using CLTA to open up cancer vaccination. I'm sure Pela would benefit from such an approach. Roche is trialing XLO's CLTA with Tencentriq and when that works out maybe they will turn to Pela. GL all. 
<< Previous
Bullboard Posts
Next >>